Nvronrabi 20mg Tablet
Images are for reference. Actual packaging may vary.
Rabeprazole (20mg)
Strip of 10 tablets • Tablet
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Rabeprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Medical applications
Nvronrabi 20mg Tablet contains Rabeprazole, a proton pump inhibitor (PPI) indicated for the treatment of acid-related gastrointestinal conditions. Rabeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This reduction in acid production provides symptomatic relief and promotes healing in conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer disease, including Helicobacter pylori-associated ulcers when used in combination therapy.
Nvronrabi is also employed for the prevention of gastric ulcers induced by nonsteroidal anti-inflammatory drugs (NSAIDs). The 20mg dosage is typically administered once daily, preferably before meals, to optimize efficacy. Rabeprazole is generally well-tolerated; however, potential adverse effects may include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term use should be monitored due to possible risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections.
Caution is advised in patients with hepatic impairment, and drug interactions should be considered, particularly with medications dependent on gastric pH for absorption. Nvronrabi 20mg Tablet should be used under medical supervision to ensure appropriate indication and dosing.
Sulfinylbenzimidazole Derivative
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Nvronrabi 20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nvronrabi 20mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nvronrabi 20mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Nvronrabi 20mg Tablet is recommended.
Exercise Caution
Nvronrabi 20mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nvronrabi 20mg Tablet is safe to use in patients with liver disease. No dose adjustment of Nvronrabi 20mg Tablet is recommended.
Regular Checkup
0 reviews for Nvronrabi 20mg Tablet







